Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From April 4th to 6th, 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- GLP compliance:
- yes
Test material
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals / tissue source
- Species:
- human
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method and considerations regarding applicability: the EpiOcularTM model is the biological model required by OECD TG 492.
- Description of the cell system used, incl. certificate of authenticity and the mycoplasma status of the cell live:
The EpiOcular TM model is manufactured by MatTek in vitro Life ScienceLaboratories (Mlynske Nivy 73, Bratislava 821 05 -Slovakia). A stratified squamous epithelium similar to the corneal epithelium is obtained from Normal, Human Epidermal Keratinocytes (NHEK), derived from Neonatal-foreskin issue, grown in a medium chemically defined without the addition of fetal serum, on specially prepared cell culture insert (9mm) at the air-liquid interface.The batch is certified for the absence of HIV, Hepatitis B, Hepatitis C ,fungi,bacteria and yeast. Media are sterile. The inserts are sent by courier at 4 ° C in 24-well plates containing an agarose gel nutritious. The plates are wrapped in a plastic container. Including time in transit, tissues shell life is 96h.
- NAME and BATCH: EpiOcularTM batch N° 23774
- STATE MANUFACTURER MatTek IVLSL
- Cell viability OD (540nm-570 nm) [range indicated by manufacturer 1.1 - 3.0]: 1.603 ± 0.058 (Accepted)
- Barrier Function: ET-50 [range indicated by manufacturer 12.2 - 37.5 min]: 15.3 min (Accepted)
- DATE OF ARRIVAL: 04.04.2017
- EXPIRATION DATE: including time in transit, tissues shell life is 96h
- PREPARATION OF CULTURE: immediately after the arrival in the laboratory the EpiOcularTM were equilibrated to room temperature for 15 minutes. Tissues were then removed from the agarose nutrient solution under a sterile air flow cabin. The inserts were rapidly placed in a 6-well plate previously filled with 1 ml of medium pre-warmed at 37°C. The wells were placed in incubator at 37 °C, 5% CO2 and saturated humidity for 1h. After the incubation period the medium was replaced with 1ml of fresh medium and tissues were incubated at 37 °C, 5% CO2 and saturated humidity overnight. The test item was applied the day after the arrival of the test system.
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- other: positive control: methyl acetate; negative control: ultrapure water
- Amount / concentration applied:
- 50 mg of test item and 50 µl of the controls were directly and uniformy topically applied.
- Duration of treatment / exposure:
- 6 hours
- Duration of post- treatment incubation (in vitro):
- 18 hours
- Number of animals or in vitro replicates:
- Two replicates for test item, positive and negative controls.
- Details on study design:
- - Details of the test procedure used: EpiOcular TM model according to OECD492 (July 2015)
- RhCE tissue construct used, including batch number: a stratified squamous epithelium similar to the corneal epithelium is obtained from Normal, Human Epidermal Keratinocytes (NHEK), derived from Neonatal-foreskin tissue, grown in a medium chemically defined without the addition of fetal serum, on specially prepared cell culture insert (9mm) at the air-liquid interface (EpiOcular TM batch N° 23774).
- Doses of test chemical and control substances used: 50μl for negative and positive controls and 50 mg of test item. Before the application the tissue surface is pre-treated with 20 μl of Ca++ and Mg++ free Dulbecco’s phosphate buffered saline.
- Duration and temperature of exposure, post-exposure immersion and post-exposure incubation periods (where applicable): the exposure was carried out for 6 hours at 37 °C, 5% CO2 and the post incubation was carried out for 18 hours always at 37 °C, 5% CO2.
- Indication of controls used for direct MTT-reducers and/or colouring test chemicals (if applicable): Not required. No colour interference and direct MTT reduction for test item.
- Number of tissue replicates used per test chemical and controls: test item, positive and negative controls were evaluated in duplicate on viable tissues. For each tissue were made two technical replicates.
- List of instruments used for the test:
ANALYTICAL BALANCE XS204
CO2 INCUBATOR
LAMINAR FLOW CABIN
MICROPLATE AUTOREADER INFINITE M200
MICROPIPETTES
REFRIGERATOR FRL 360
NEX POWER 1000 SYSTEM
- Wavelength and band pass (if applicable) used for quantifying MTT formazan, and linearity range of measuring device (e.g. spectrophotometer): optical density measured at 570 nm with TECAN INFINITE M-200 spectrophotometer is used for quantifying MTT formazan.
- Description of the method used to quantify MTT formazan: the method allows to evaluate a toxic event and related cytotoxicity by a colorimetric assay. Mitochondrial dehydrogenase of viable cells cleaves the tetrazolium ring yielding blue/purple MTT crystals which are insoluble in aqueous solutions. MTT crystals are extracted and optical density is measured at 570 nm.
- Data Acquisition: the accuracy of the spectro-photometrical measurements are in the range between 0 and 2 OD: < +/-(1% +10 mOD). The Raw data of OD were directly recorded in the Microplate autoreader (TECAN INFINITE M-200), reported in a Excel file and further processed (Software Magellan Tracker 6.5).
For each tissue were made two technical replicates.
The mean of 8 Blank OD (2-propanol) was subtracted to every single OD value.
The Biological Replicate OD mean was calculated on two technical replicates.
The viabilty of each Biological Replicate was calculated dividing the respective OD mean for the optical density average of the two Negative Control (NC) Biological Replicates in accordance with the following formula:
% Viability= (OD biological replicate Positive Control or sample/mean OD of Negative Control biological replicates)*100
The viability % mean of the two tissues treated with the same substance was calculated.
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model: according to the United Nations Globally Harmonized System (UN GHS) of Classification and Labelling of Chemicals and EU CLP (EC) No 1272/2008 if the mean relative tissue viability (%) of treated tissues exposed to the test substance is > 60 % the test substance is identified as not requiring classification and labelling(NO Category). If the mean relative viability is ≤ 60 % the test substance is identified as potentially requiring classification and labelling as Category 1 (risk phrase H318: causes serious eye damage) or Category 2 (risk phrase H319: Causes serious eye irritation). No further discrimination within Category 1 and Category 2 is possible. This evaluation criteria are the same reported in section ' Interpretation of Results and Prediction Model' of OECD 492 (July 2015)
- Acceptable variability between tissue replicates for positive and negative controls: for positive and negative controls the difference of viability between the 2 tissues replicates must be < 20 %. Moreover for negative control mean OD value of 2 tissue must be > 0.8 and < 2.5 and for positive control the mean cell viability expressed as percentage compared to negative control must be < 50 %.
- Acceptable variability between tissue replicates for the test chemical: for test item the difference of viability between the 2 tissues replicates must be < 20 %. If the colorant control result and/or the direct reduction of MTT by the test item is> 50 % of the viable negative control, the product may be considered as not testable.
- Statistics: no specific statistical analysis has been carried out except the standard deviation calculations.
Results and discussion
In vitro
Results
- Irritation parameter:
- in vitro irritation score
- Run / experiment:
- Mean of two replicates
- Value:
- ca. 66.94
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: negative control meets the acceptance if the mean OD negative control value of the 2 tissues is > 0,8 and < 2,5 and if the difference of viability between the 2 tissues replicates is < 20 %.
Values OD mean of two tissues for negative control: 1.7748 and 1.7888, Mean: 1.7818 inside range 0.8 - 2.5. Difference of viability between the 2 tissues replicates for negative control : 100.39 - 99.61 = 0.78 % < 20 % .
Based on these considerations the acceptance criteria for negative control were satisfied.
- Acceptance criteria met for positive control: positive control meets the acceptance criteria if mean cell viability expressed as percentage compared to negative control is < 50% and if the difference of viability between the 2 tissues replicates is < 20%.
Mean cell viability for positive control: 12.61 % < 50 %. Difference of viability between the 2 tissues replicates for positive control: 14.27 - 10.94 = 3.33 % < 20 % .
Based on these considerations the acceptance criteria for positive control were satisfied.
- Acceptance criteria for test item: for test item the difference of viability between the 2 tissues replicates must be < 20 %. Difference of viability between the 2 tissues replicates for positive control: 69.39 - 64.49 = 4.9 % < 20 % .
Based on these considerations the acceptance criteria for test item were satisfied.
Applicant's summary and conclusion
- Interpretation of results:
- other: not eye irritant according to the CLP Regulation (EC n.1272/2008)
- Conclusions:
- Non-eye irritant.
- Executive summary:
The study was conducted in order to assess the eye irritation of the test item using the EpiOcularTMEye Irritation Test (EIT) according to OECD TG 492 (July 2015) specific for solid chemicals. Eye irritation was assessed at 6h exposure followed by product washing and a post incubation period of 18 h by using the MIT test method to quantify the residual cell viability. Based on the adopted prediction model and to MIT results (66.94 %) the test item was not irritant according to UN GHS and according to the CLP Regulation (EC n.1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.